Showing 41,601 - 41,620 results of 65,058 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( a ((non decrease) OR (point decrease)) ))', query time: 1.61s Refine Results
  1. 41601

    Mitochondrial genome sequencing with short overlapping amplicons on MiSeq FGx system by Yang Xin (286771)

    Published 2022
    “…Concordant haplotypes of 9947 A and 2800 M were obtained at 32 variants. Cross-reactivity was observed with 1 ng primate DNA and 10 ng non-primate DNA but could be easily distinguished. …”
  2. 41602

    IL-4 induced CCL26 expression is inhibited by PLAG. by Jinseon Jeong (2579929)

    Published 2016
    “…PLAG decreased CCL26 secretion from A549 cells from the early time point. …”
  3. 41603

    Spontaneous nicotine withdrawal measured after 7 days of nicotine exposure (5.2 mg/rat/day). by Andrea Cippitelli (194306)

    Published 2011
    “…<p>Rats previously exposed to nicotine showed (<b>A</b>) increased occurrence of overall withdrawal signs compared to non-exposed controls. …”
  4. 41604
  5. 41605
  6. 41606
  7. 41607

    Altered CaMKIIα mRNA and protein synaptic localization disrupts olfactory associative learning. by Marie Néant-Fery (317696)

    Published 2013
    “…<p><b>A, </b><i>In situ</i> hybridization for CaMKIIα mRNA in wild-type mice (WT, upper panels) and 3′UTR mutants (3′UTR, lower panels) shows a dramatic decrease of the dendritic staining (stars) in the mutant hippocampus (HC, left panels) and olfactory bulb (OB, right panels). …”
  8. 41608
  9. 41609
  10. 41610

    Genetic Variation in 15-Hydroxyprostaglandin Dehydrogenase and Colon Cancer Susceptibility by Cheryl L. Thompson (375169)

    Published 2013
    “…Recent studies have established the 15-PGDH gene as a colon cancer suppressor.</p><p>Methods</p><p>We evaluated 15-PDGH as a colon cancer susceptibility locus in a three-stage design. …”
  11. 41611
  12. 41612
  13. 41613
  14. 41614
  15. 41615

    Effects of facilitated diffusion on elongation. by Alain Mechulam (268237)

    Published 2009
    “…The regime III occurs for <i>Uc = −6 K<sub>B</sub>T</i> and we can observe a rapid decrease of <i>J<sub>facilitated</sub></i> with L. …”
  16. 41616

    Image1_Neuronal nitric oxide synthase required for erythropoietin modulation of heart function in mice.pdf by Jeeyoung Lee (2638744)

    Published 2024
    “…</p><p>Results: ΔEPORE mice showed a decrease in the left ventricular outflow tract (LVOT) peak velocity, ejection fraction, and fractional shortening, showing that endogenous non-erythroid EPO response is protective for heart function. …”
  17. 41617

    Image3_Neuronal nitric oxide synthase required for erythropoietin modulation of heart function in mice.pdf by Jeeyoung Lee (2638744)

    Published 2024
    “…</p><p>Results: ΔEPORE mice showed a decrease in the left ventricular outflow tract (LVOT) peak velocity, ejection fraction, and fractional shortening, showing that endogenous non-erythroid EPO response is protective for heart function. …”
  18. 41618

    Table1_Neuronal nitric oxide synthase required for erythropoietin modulation of heart function in mice.docx by Jeeyoung Lee (2638744)

    Published 2024
    “…</p><p>Results: ΔEPORE mice showed a decrease in the left ventricular outflow tract (LVOT) peak velocity, ejection fraction, and fractional shortening, showing that endogenous non-erythroid EPO response is protective for heart function. …”
  19. 41619

    Image2_Neuronal nitric oxide synthase required for erythropoietin modulation of heart function in mice.pdf by Jeeyoung Lee (2638744)

    Published 2024
    “…</p><p>Results: ΔEPORE mice showed a decrease in the left ventricular outflow tract (LVOT) peak velocity, ejection fraction, and fractional shortening, showing that endogenous non-erythroid EPO response is protective for heart function. …”
  20. 41620

    Image4_Neuronal nitric oxide synthase required for erythropoietin modulation of heart function in mice.pdf by Jeeyoung Lee (2638744)

    Published 2024
    “…</p><p>Results: ΔEPORE mice showed a decrease in the left ventricular outflow tract (LVOT) peak velocity, ejection fraction, and fractional shortening, showing that endogenous non-erythroid EPO response is protective for heart function. …”